~90% of patients pay $10 or less with financial assistance offerings1
For all new,
non-sampled patients
30-day Free Trial Voucher
New, non-sampled patients can receive
their first
30 days of AUSTEDO XR for free.
Voucher available at
AUSTEDOcardform.com.
Remind pharmacy to apply.
For eligible patients with
commercial insurance
Copay Card
Patients may pay as little as $0 per
month for AUSTEDO XR.
Patients must self-enroll at
MySharedSolutions.com.
Visit AUSTEDOcardform.com to send a
link
to patients with more information.
For patients with
Medicare Part D
Low-income Subsidy
(LIS)
Patients who qualify for and utilize LIS
may pay as little as $10.35 per month.2
Shared Solutions can help patients understand if they qualify. To enroll in Shared Solutions, patients can visit MySharedSolutions.com.
For uninsured or
underinsured patients
Patient Assistance Program
(PAP)
To qualify, patient must:
- Apply for assistance
- Be a legal US resident
- Meet the insurance
eligibility criteria - Be below the income
eligibility limit
To apply, patient must complete the application on MySharedSolutions.com.
~88% of AUSTEDO prescriptions are successfully processed and approved1
- Access for 94% of patients with insurance coverage (commercial, Medicare Part D, and Medicaid)1
- Available at both specialty and retail pharmacies
Request a visit from a Patient Support Specialist who can help with access and reimbursement, prescription pull-through, and patient assistance support*
*If you do not have a Patient Support Specialist, reach out to your sales representative.
Prescription
coverage tool
Find health plans that cover AUSTEDO® XR (deutetrabenazine) extended-release tablets in your state
Find health plans that cover AUSTEDO® XR (deutetrabenazine) extended-release tablets in your state
Enter in a ZIP code or select a state, then select a plan type, select a plan, and click “Search.”
Or
State
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Puerto Rico
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Plan Type
- Commercial
- DME MAC
- EGWP
- Employer
- Fed Prog
- FEHBP
- HIX
- IDN/HOSP
- MAC A
- MAC B
- Managed Medicaid
- Medicare MA
- Medicare PDP
- Medicare SN
- Medi-Medi
- Municipal Plan
- PACE
- PBM
- Pvt HIX
- State Medicaid
- Union
Select Plan
NA, not available.
Please note that plans may have multiple formularies and they are subject to change by the plan. Please check with the health plan directly to confirm formulary status, requirements, and coverage information for individual patients.
Source: Fingertip Formulary database as of 10/2023.
This information is intended only to show the formulary coverage status for each product and should not be construed to make any comparisons of safety, efficacy, or other clinical outcome.
REFERENCES: 1. Data on file. Parsippany, NJ: Teva Neuroscience, Inc. 2. Medicare. Find your level of Extra Help (Part D). Accessed January 9, 2023. https://www.medicare.gov/your-medicare-costs/get-help-paying-costs/find-your-level-of-extra-help-part-d